Lexaria Bioscience News

Lexaria Bioscience Analyst Ratings

BenzingaDec 2 06:36 ET

H.C. Wainwright Maintains Lexaria Bioscience(LEXX.US) With Buy Rating, Maintains Target Price $10

Moomoo NewsDec 2 06:31 ET

H.C. Wainwright Maintains Lexaria Bioscience(LEXX.US) With Buy Rating, Maintains Target Price $10

Moomoo NewsNov 25 07:31 ET

HC Wainwright & Co. Reiterates Buy on Lexaria Bioscience, Maintains $10 Price Target

BenzingaNov 25 07:04 ET

Lexaria Bioscience Analyst Ratings

BenzingaNov 25 07:02 ET

Maxim Group Maintains Lexaria Bioscience(LEXX.US) With Buy Rating, Maintains Target Price $12

Moomoo NewsSep 14 08:31 ET

Maxim Group Maintains Lexaria Bioscience(LEXX.US) With Buy Rating, Maintains Target Price $12

Moomoo NewsSep 13 12:31 ET

Lexaria Bioscience Analyst Ratings

BenzingaJul 18 12:41 ET

Buy Rating on Lexaria Bioscience Fueled by Promising DehydraTECH Advances in Diabetes Drug Development

TipRanksJul 18 09:18 ET

Lexaria Bioscience Analyst Ratings

BenzingaJul 10 06:48 ET

Analysts Offer Insights on Healthcare Companies: Inventiva (IVA), Lexaria Bioscience (LEXX) and Guardant Health (GH)

TipRanksMay 22 07:35 ET

Lexaria Bioscience Analyst Ratings

BenzingaMar 5 11:41 ET

Analysts Offer Insights on Healthcare Companies: Lexaria Bioscience (LEXX), Evolus (EOLS) and Inspire Medical Systems (INSP)

TipRanksJan 22 15:01 ET

Buy Rating on Lexaria Bioscience: Promising DehydraTECH Study and Market Potential

TipRanksNov 29, 2023 15:15 ET

Maxim Group Remains a Buy on Lexaria Bioscience (LEXX)

TipRanksAug 3, 2023 15:05 ET

Maxim Group Sticks to Their Buy Rating for Lexaria Bioscience (LEXX)

TipRanksJul 29, 2023 13:05 ET

Maxim Group Initiates Coverage On Lexaria Bioscience With Buy Rating, Announces Price Target of $2

BenzingaJul 21, 2023 10:00 ET

Lexaria Bioscience Analyst Ratings

BenzingaJul 21, 2023 09:59 ET

Watching Lexaria Bioscience; Hearing Zacks Small-Cap Research Sets $15 Price Target

Benzinga Real-time NewsJan 17, 2023 12:02 ET